Equity

Quarterly ResultsHome > Equity > Corporate Information > Quarterly Results

Vivimed Labs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532660 NSE Symbol: VIVIMEDLAB P/E (TTM) :0
ISIN Demat:INE526G01021 Div & Yield %:0 EPS (TTM) :0
Book Value (RS) :7.4280394 Market Cap (Rs Cr.):40.63 Face Value (RS) :2
    Change Company 
Quarters :  
ParticularsDec 2023Sep 2023Jun 2023Mar 2023
 (Rs in Cr)(Rs in Cr)(Rs in Cr)(Rs in Cr)
Gross Sales 37.1430.2833.0039.72
Other Operating Income 0.000.000.000.00
Other Income  0.042.160.010.00
Total Income 37.1732.4433.0139.72
Total Expenditure  36.2535.6933.29203.49
PBIDT 0.92-3.25-0.28-163.77
Interest  13.1611.8210.618.07
PBDT -12.24-15.07-10.90-171.84
Depreciation 4.494.494.4995.07
Tax 0.000.000.000.00
Fringe Benefit Tax 0.000.000.000.00
Deferred Tax -0.550.000.00-2.07
Reported Profit After Tax -16.17-19.56-15.38-264.85
Extra-ordinary Items  0.000.000.000.00
Adjusted Profit After Extra-ordinary item -16.17-19.56-15.38-264.85
     
EPS (Unit Curr.) -1.95-2.36-1.86-31.94
EPS (Adj) (Unit Curr.) -1.95-2.36-1.86-31.94
Calculated EPS (Unit Curr.) -1.95-2.36-1.86-31.94
Calculated EPS (Adj) (Unit Curr.) -1.95-2.36-1.86-31.94
Calculated EPS (Ann.) (Unit Curr.) -7.80-9.44-7.42-127.77
Calculated EPS (Adj) (Ann.) (Unit Curr.) -7.80-9.44-7.42-127.77
Book Value (Unit Curr.) 0.000.000.000.00
Dividend (%) 0.000.000.000.00
Equity 16.5816.5816.5816.58
Reserve & Surplus 0.000.000.000.00
Face Value 2.002.002.002.00
     
Public Shareholding (No. Of Shares) 0.000.000.000.00
Public Shareholding (% in Equity) 0.000.000.000.00
     
Pledged/Encumbered - No. of Shares 0.000.000.000.00
Pledged/Encumbered - % in Total Promoters Holding 0.000.000.000.00
Pledged/Encumbered - % in Total Equity 0.000.000.000.00
     
Non Encumbered - No. of Shares 0.000.000.000.00
Non Encumbered - % in Total Promoters Holding 0.000.000.000.00
Non Encumbered - % in Total Equity 0.000.000.000.00
     
PBIDTM(%) 2.48-10.73-0.85-412.31
PBDTM(%) -32.96-49.77-33.03-432.63
PATM(%) -43.54-64.60-46.61-666.79

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)